Book Whole Exome Sequencing (WES) | Lahalak Medical Platform

An advanced genomic analysis covering protein-coding regions to identify rare mutations in atypical cancer presentations, providing crucial insights for precise diagnostic accuracy and personalized treatment strategies.

Scientific name: Whole Exome Sequencing (WES) for Rare Malignancies

A sophisticated laboratory test analyzing the entire exome sequence to detect rare genetic mutations linked to malignancies. It aids clinicians in identifying precise therapeutic targets for atypical cancers.

Whole Exome Sequencing (WES) for Rare Malignancies - Genomic Blueprint for Rare Cancers
Service type Laboratory genetic test
Duration 30-45 minutes
Fasting Fasting is not required

Included Services

  • Blood sample or swab collection
  • Exome sequence analysis
  • Detailed laboratory results report

Medical Service Information

Purpose of the Test

  • Identify genetic mutations causing atypical malignancies.
  • Provide genomic data to personalize chemotherapy or immunotherapy.
  • Detect hereditary syndromes associated with rare tumor presentations.

Target Groups

  • Patients with rare or unexplained tumors.
  • Cases that have not responded to conventional cancer treatments.
  • Individuals with a strong family history of rare cancers.

Importance of Genetic Testing

  • Contributes to precision medicine by selecting the most effective drug.
  • Reduces trial-and-error with ineffective treatments based on genetics.
  • Helps in predicting the future course of the disease.

Conditions & Notices

  • Previous medical reports preferred
  • Signed genetic testing consent form

Medical services you might also like